{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:05:23Z","timestamp":1756339523813,"version":"3.44.0"},"reference-count":9,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,1,29]]},"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:p>A 6-month-old girl presented to hospital via ambulance with a decreased conscious level (initial Glasgow Coma Scale of 3) and an abnormal breathing pattern described as diaphragmatic flutter. She then developed abnormal movements and continued to have episodes of fluctuating conscious levels so was transferred to a tertiary hospital paediatric intensive care unit for further investigation. During her 16-day stay in hospital, she continued to experience discrete episodes of drowsiness, bradycardia, unusual breathing patterns and abnormal movements which were associated with agitation, tachycardia, hypertension and insomnia. The patient underwent extensive investigation for her symptoms and, after some delay in waiting for initial results before considering a urine drug screen, she was ultimately found to have lisdexamfetamine and clonidine in her urine drug screen. Her symptoms subsequently resolved after her mother\u2019s visits were restricted.<\/jats:p>","DOI":"10.1136\/bcr-2020-236962","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T13:15:46Z","timestamp":1617801346000},"page":"e236962","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Abnormal movements and diaphragmatic flutter in a case of suspected induced illness"],"prefix":"10.1136","volume":"14","author":[{"given":"Rebecca","family":"Arvier","sequence":"first","affiliation":[{"name":"General Paediatrics, Queensland Children's Hospital, South Brisbane, Queensland, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Clayton","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Queensland Children's Hospital, South Brisbane, Queensland, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique","family":"Dade","sequence":"additional","affiliation":[{"name":"General Paediatrics, Queensland Children's Hospital, South Brisbane, Queensland, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul S","family":"Joshi","sequence":"additional","affiliation":[{"name":"Paediatric Intensive Care Medicine, Queensland Children's Hospital, South Brisbane, Queensland, Australia"},{"name":"Children's Critical Care, Gold Coast University Hospital, Southport, Queensland, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,4,7]]},"reference":[{"key":"2025082708580474000_14.4.e236962.1","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s13181-016-0560-x","article-title":"An infant with a prolonged sympathomimetic toxidrome after lisdexamfetamine dimesylate ingestion","volume":"12","author":"Wood","year":"2016","journal-title":"J Med Toxicol"},{"key":"2025082708580474000_14.4.e236962.2","unstructured":"Therapeutic Guidelines . Using psychotropic drugs in children, eTG June 2019, 2013."},{"key":"2025082708580474000_14.4.e236962.3","unstructured":"Therapeutic Goods Administration . Australian public assessment report for lisdexamfetamine dimesilate. Australian public assessment record, 2013."},{"key":"2025082708580474000_14.4.e236962.4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s40263-013-0084-8","article-title":"Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management","volume":"27","author":"Spiller","year":"2013","journal-title":"CNS Drugs"},{"key":"2025082708580474000_14.4.e236962.5","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1164\/ajrccm.164.7.2104085","article-title":"Respiratory flutter syndrome: an underrecognized cause of respiratory failure in neonates","volume":"164","author":"Katz","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2025082708580474000_14.4.e236962.6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nrl.2013.06.016","article-title":"Diaphragmatic flutter: a case report and literature review","volume":"30","author":"Ram\u00edrez","year":"2015","journal-title":"Neurologia"},{"key":"2025082708580474000_14.4.e236962.7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.farma.2010.06.001","article-title":"Respiratory myoclonus, a side effect of galantamine","volume":"35","author":"Hern\u00e1ndez-Fern\u00e1ndez","year":"2011","journal-title":"Farm Hosp"},{"key":"2025082708580474000_14.4.e236962.8","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20312"},{"key":"2025082708580474000_14.4.e236962.9","article-title":"Belly dancer's dyskinesia: a glimpse of a rare phenomenon","volume":"9","author":"Gupta","year":"2017","journal-title":"Cureus"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-236962","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:58:13Z","timestamp":1756310293000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-236962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":9,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,7]]},"published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1136\/bcr-2020-236962"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-236962","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}